AMGEN TO PRESENT AT THE 40TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

Rhea-AI Summary

Amgen (NASDAQ:AMGN) will virtually present at the 40th Annual J.P. Morgan Healthcare Conference on January 11, 2022, at 11:15 a.m. ET. CEO Robert A. Bradway will lead the presentation. The live audio will be available for media, investors, and the public via Amgen's website, where it will also be archived for at least 90 days. Amgen is renowned for its innovative human therapeutics, focusing on high unmet medical needs since its inception in 1980. It is part of the Dow Jones Industrial Average and Nasdaq-100, recognized as one of the world's best workplaces and sustainable companies.

THOUSAND OAKS, Calif., Jan. 6, 2022 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will virtually present at the 40^th Annual J.P. Morgan Healthcare Conference at 11:15 a.m. ET on Tuesday, Jan. 11, 2022. Robert A. Bradway, chairman and chief executive officer at Amgen will present at the conference. Live audio of the conference call will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.

The webcast, as with other selected presentations regarding developments in Amgen's business given at certain investor and medical conferences, can be accessed on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.

About Amgen Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.  

Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.  

Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average and is also part of the Nasdaq-100 index.  In 2021, Amgen was named one of the 25 World's Best Workplaces™ by Fortune and Great Place to Work™ and one of the 100 most sustainable companies in the world by Barron's.

For more information, visit www.amgen.com and follow us on www.twitter.com/amgen.  

CONTACT: Amgen, Thousand Oaks 
Megan Fox, 805-447-1423 (media)
Michael Strapazon, 805-313-5553 (media) 
Arvind Sood, 805-447-1060 (investors) 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/amgen-to-present-at-the-40th-annual-jp-morgan-healthcare-conference-301455836.html

SOURCE Amgen

FAQ

When will Amgen present at the J.P. Morgan Healthcare Conference?

Amgen will present on January 11, 2022, at 11:15 a.m. ET.

Who is presenting for Amgen at the conference?

CEO Robert A. Bradway will present at the J.P. Morgan Healthcare Conference.

How can I listen to Amgen's conference presentation?

The live audio will be available on Amgen's website and will also be archived for at least 90 days.

What is Amgen's focus in the biotechnology sector?

Amgen focuses on unlocking biology's potential to create innovative therapeutics for serious illnesses.

What recognition has Amgen received in 2021?

In 2021, Amgen was named one of the 25 World's Best Workplaces and one of the 100 most sustainable companies.